T&R Biofab Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 86

Employees

  • Stock Symbol
  • 246710

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $1.38
  • (As of Thursday Closing)

T&R Biofab General Information

Description

T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 96, Mayu-ro
  • Siheung, Gyeonggi
  • South Korea
+82
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Surgical Devices
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 96, Mayu-ro
  • Siheung, Gyeonggi
  • South Korea
+82

T&R Biofab Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

T&R Biofab Stock Performance

As of 12-Nov-2026, T&R Biofab’s stock price is $1.38. Its current market cap is $65.7M with 47.6M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.38 $1.35 $0.77 - $3.33 $65.7M 47.6M 170K -$0.56

T&R Biofab Financials Summary

As of 30-Jun-2026, T&R Biofab has a trailing 12-month revenue of $22.6M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 78,388 110,642 74,203 140,282
Revenue 22,554 18,949 3,572 3,977
EBITDA (12,452) (14,837) (2,515) (9,894)
Net Income (19,095) (22,451) (5,628) (10,263)
Total Assets 60,113 64,384 66,840 77,456
Total Debt 19,785 20,529 30,007 35,712
Public Fundamental Data provided by Morningstar, Inc. disclaimer

T&R Biofab Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore T&R Biofab‘s full profile, request access.

Request a free trial

T&R Biofab Patents

T&R Biofab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026182320-A1 Method for manufacturing semipermeable absorbent mesh using decellularized natural polymer Pending 25-Feb-2025
WO-2026071301-A1 Absorbable composite hemostatic agent for internal use and manufacturing method therefor Pending 30-Sep-2024
WO-2026071302-A1 Absorbable internal hemostasis kit and absorbable internal hemostatic agent Pending 30-Sep-2024
EP-4556556-A1 Method for purification and production of ventricular cardiomyocytes Pending 21-Sep-2023
EP-4556556-A4 Method for purification and production of ventricular cardiomyocytes Pending 21-Sep-2023 C12N5/0657
To view T&R Biofab’s complete patent history, request access »

T&R Biofab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

T&R Biofab Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore T&R Biofab‘s full profile, request access.

Request a free trial

T&R Biofab Investments & Acquisitions (2)

T&R Biofab’s most recent deal was a Merger/Acquisition with Blisspack. The deal was made on 23-Apr-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Blisspack 23-Apr-2024 Merger/Acquisition Plastic Containers and Packaging
Mi-face (Land and Buildings in Siheung, South Korea) 14-Oct-2021 Corporate Asset Purchase Buildings and Property
To view T&R Biofab’s complete investments and acquisitions history, request access »

T&R Biofab ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view T&R Biofab’s complete esg history, request access »

T&R Biofab Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Blisspack Siheung Si, South Korea 2002

T&R Biofab FAQs

  • When was T&R Biofab founded?

    T&R Biofab was founded in 2013.

  • Where is T&R Biofab headquartered?

    T&R Biofab is headquartered in Siheung, South Korea.

  • What is the size of T&R Biofab?

    T&R Biofab has 86 total employees.

  • What industry is T&R Biofab in?

    T&R Biofab’s primary industry is Other Devices and Supplies.

  • Is T&R Biofab a private or public company?

    T&R Biofab is a Public company.

  • What is T&R Biofab’s stock symbol?

    The ticker symbol for T&R Biofab is 246710.

  • What is the current stock price of T&R Biofab?

    As of 12-Nov-2026 the stock price of T&R Biofab is $1.38.

  • What is the current market cap of T&R Biofab?

    The current market capitalization of T&R Biofab is $65.7M.

  • What is T&R Biofab’s current revenue?

    The trailing twelve month revenue for T&R Biofab is $22.6M.

  • What is T&R Biofab’s annual earnings per share (EPS)?

    T&R Biofab’s EPS for 12 months was -$0.56.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process